Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002098243-25-000003
Filing Date
2025-11-25
Accepted
2025-11-25 18:06:11
Documents
4
Period of Report
2025-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1764111967.html 3  
1 FORM 3 wk-form3_1764111967.xml 3 2148
2 EX-24 poaadhankhar.htm EX-24 877
3 GRAPHIC poaadhankhar001.jpg GRAPHIC 192419
4 poaadhankhar002.jpg GRAPHIC 80862
  Complete submission text file 0002098243-25-000003.txt   381079
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Issuer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O BIOVENTUS INC. 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address
Dhankhar Ajay (Reporting) CIK: 0002098243 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37844 | Film No.: 251523003